Literature DB >> 3816319

Pulmonary function in the Marfan syndrome.

E A Streeten, E A Murphy, R E Pyeritz.   

Abstract

To explore the causes of reported abnormalities in pulmonary function in persons with the Marfan syndrome, we analyzed retrospective anthropometric and pulmonary function tests in 79 patients. For ten subjects, there were matched, related control subjects who did not have a connective tissue disorder. Patients had lower values of FVC and TLC than the values expected for their standing heights (83 and 91 percent). However, when sitting height was used to calculate expected spirometric values, patients free of severe deformity of the thoracic cage did not have significant spirometric abnormalities (FVC 105 percent, FEV1 92 percent). However, patients with moderate-to-severe pectus excavatum or scoliosis (common features of the Marfan syndrome) had marked reductions in total lung capacity as well as in FVC and FEV1, suggesting a restrictive ventilatory defect. The abnormalities of pulmonary function often found in clinical laboratories can be explained in most cases by inappropriate use of standing height to calculate expected values, by thoracic cage deformity, or by both. We have found no evidence from standard tests of pulmonary function for a connective tissue defect of lung parenchyma that is of clinical importance in Marfan patients who lack chest wall deformity.

Entities:  

Mesh:

Year:  1987        PMID: 3816319     DOI: 10.1378/chest.91.3.408

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

Review 2.  Non-cardiac manifestations of Marfan syndrome.

Authors:  Anne H Child
Journal:  Ann Cardiothorac Surg       Date:  2017-11

3.  Dural ectasia is a common feature of the Marfan syndrome.

Authors:  R E Pyeritz; E K Fishman; B A Bernhardt; S S Siegelman
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

4.  Spinal fusion in pediatric patients with marfan syndrome: a nationwide assessment on short-term outcomes and readmission risk.

Authors:  Michael W Fields; Nathan J Lee; Jacob R Ball; Venkat Boddapati; Justin Mathew; Daniel Hong; Josephine R Coury; Zeeshan M Sardar; Benjamin Roye; Michael Vitale; Lawrence G Lenke
Journal:  Eur Spine J       Date:  2020-10-19       Impact factor: 3.134

5.  Marfan syndrome with pneumothorax: case report and review of literatures.

Authors:  Weiming Hao; Yong Fang; Hao Lai; Yaxing Shen; Hao Wang; Miao Lin; Lijie Tan
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

6.  The correlation between spinal and chest wall deformities and pulmonary function in Marfan syndrome.

Authors:  Hila Otremski; Roger F Widmann; Mary F Di Maio; Dror Ovadia
Journal:  J Child Orthop       Date:  2020-08-01       Impact factor: 1.548

Review 7.  Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson
Journal:  Appl Clin Genet       Date:  2015-06-16

8.  Orthopaedic Aspects of Marfan Syndrome: The Experience of a Referral Center for Diagnosis of Rare Diseases.

Authors:  Fernando De Maio; Alessandro Fichera; Vincenzo De Luna; Federico Mancini; Roberto Caterini
Journal:  Adv Orthop       Date:  2016-12-05

9.  Lung Function Changes are More Common in Marfan Patients Who Need Major Thoracic Surgery.

Authors:  Abigel M Kolonics-Farkas; Bence Agg; Kalman Benke; Balazs Odler; Aniko Bohacs; Zsuzsanna Kovats; Zoltan Szabolcs; Veronika Müller
Journal:  Lung       Date:  2019-05-14       Impact factor: 2.584

10.  Early Impairment of Lung Mechanics in a Murine Model of Marfan Syndrome.

Authors:  Juan J Uriarte; Thayna Meirelles; Darya Gorbenko Del Blanco; Paula N Nonaka; Noelia Campillo; Elisabet Sarri; Daniel Navajas; Gustavo Egea; Ramon Farré
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.